Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer.
Saved in:
| Title: | Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer. |
|---|---|
| Authors: | Michel LL; National Center for Tumor Diseases, Heidelberg University Hospital, German Cancer Research Center (DKFZ), Heidelberg, Germany., Ziegler P; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany., Kreis P; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany., Hartkopf AD; Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany., Wallwiener M; Department of Gynecology, Halle University Hospital, Halle, Germany., Häberle L; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany; Biostatistics Unit, Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Erlangen, Germany., John N; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany; Biostatistics Unit, Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Erlangen, Germany., Kolberg HC; Department of Gynecology and Obstetrics, Marienhospital Bottrop, Bottrop, Germany., Hadji P; Frankfurt Center for Bone Health and Endocrinology, Frankfurt am Main, Germany., Tesch H; Oncology Practice, Bethanien Hospital, Frankfurt am Main, Germany., Ettl J; Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany; Cancer Center Kempten/ Allgäu (CCKA), Klinikum Kempten, Kempten Germany., Lüftner D; Immanuel Hospital Märkische Schweiz & Immanuel Campus Rüdersdorf, Medical University of Brandenburg Theodor-Fontane, Rüdersdorf bei Berlin, Germany., Müller V; Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany., Belleville E; ClinSol GmbH & Co KG, Würzburg, Germany., Wimberger P; National Center for Tumor Diseases Dresden and Department of Gynecology and Obstetrics, University Hospital Dresden, TU Dresden, Dresden, Germany., Enzinger HM; Klinik für Frauenheilkunde und Geburtshilfe, Sozialstiftung Bamberg, Klinikum Bamberg, Bamberg, Germany., Huebner H; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany., Uhrig S; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany., Hack CC; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany., Krabisch P; Klinikum Chemnitz gGmbH, Medizincampus Chemnitz der Technischen Universität Dresden, Dresden, Germany., Fasching PA; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany. Electronic address: peter.fasching@uk-erlangen.de., Wuerstlein R; Breast Center and CCC Munich, Dept of Gynecology and Obstetrics, University Hospital LMU Munich, Munich, Germany., Untch M; Department of Gynecology and Obstetrics, Helios Clinics Berlin-Buch, Berlin, Germany., Ditsch N; Gynecology, Obstetrics and Senology, Faculty of Medicine, University of Augsburg, Breast Center, University Hospital Augsburg, Augsburg, Germany; CCC WERA, Germany., Hein A; Department of Gynecology and Obstetrics, Klinikum Esslingen, Esslingen, Germany., Janni W; Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany., Taran FA; Department of Gynecology and Gynecologic Oncology, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Medical Faculty and University Clinic of Cologne, University of Cologne, Cologne, Germany., Lux MP; Department of Gynecology and Obstetrics, Frauenklinik St. Louise, Paderborn, St. Josefs-Krankenhaus, Salzkotten, Germany; St. Vincenz Kliniken Salzkotten + Paderborn, Paderborn, Germany., Wallwiener D; Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany., Brucker SY; Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany., Fehm TN; Department of Gynecology and Obstetrics, Düsseldorf University Hospital, Düsseldorf, Germany; Center for Integrated Oncology Aachen Bonn Köln Düsseldorf, Düsseldorf, Germany., Schneeweiss A; National Center for Tumor Diseases, Heidelberg University Hospital, German Cancer Research Center (DKFZ), Heidelberg, Germany., Goossens C; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany., Engler T; Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany. |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Sep 09; Vol. 227, pp. 115689. Date of Electronic Publication: 2025 Aug 05. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40780076 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Michel+LL%22">Michel LL</searchLink>; National Center for Tumor Diseases, Heidelberg University Hospital, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Ziegler+P%22">Ziegler P</searchLink>; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Kreis+P%22">Kreis P</searchLink>; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Hartkopf+AD%22">Hartkopf AD</searchLink>; Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Wallwiener+M%22">Wallwiener M</searchLink>; Department of Gynecology, Halle University Hospital, Halle, Germany.<br /><searchLink fieldCode="AU" term="%22Häberle+L%22">Häberle L</searchLink>; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany; Biostatistics Unit, Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22John+N%22">John N</searchLink>; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany; Biostatistics Unit, Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Kolberg+HC%22">Kolberg HC</searchLink>; Department of Gynecology and Obstetrics, Marienhospital Bottrop, Bottrop, Germany.<br /><searchLink fieldCode="AU" term="%22Hadji+P%22">Hadji P</searchLink>; Frankfurt Center for Bone Health and Endocrinology, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Tesch+H%22">Tesch H</searchLink>; Oncology Practice, Bethanien Hospital, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Ettl+J%22">Ettl J</searchLink>; Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany; Cancer Center Kempten/ Allgäu (CCKA), Klinikum Kempten, Kempten Germany.<br /><searchLink fieldCode="AU" term="%22Lüftner+D%22">Lüftner D</searchLink>; Immanuel Hospital Märkische Schweiz & Immanuel Campus Rüdersdorf, Medical University of Brandenburg Theodor-Fontane, Rüdersdorf bei Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Müller+V%22">Müller V</searchLink>; Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Belleville+E%22">Belleville E</searchLink>; ClinSol GmbH & Co KG, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Wimberger+P%22">Wimberger P</searchLink>; National Center for Tumor Diseases Dresden and Department of Gynecology and Obstetrics, University Hospital Dresden, TU Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Enzinger+HM%22">Enzinger HM</searchLink>; Klinik für Frauenheilkunde und Geburtshilfe, Sozialstiftung Bamberg, Klinikum Bamberg, Bamberg, Germany.<br /><searchLink fieldCode="AU" term="%22Huebner+H%22">Huebner H</searchLink>; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Uhrig+S%22">Uhrig S</searchLink>; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Hack+CC%22">Hack CC</searchLink>; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Krabisch+P%22">Krabisch P</searchLink>; Klinikum Chemnitz gGmbH, Medizincampus Chemnitz der Technischen Universität Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Fasching+PA%22">Fasching PA</searchLink>; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany. Electronic address: peter.fasching@uk-erlangen.de.<br /><searchLink fieldCode="AU" term="%22Wuerstlein+R%22">Wuerstlein R</searchLink>; Breast Center and CCC Munich, Dept of Gynecology and Obstetrics, University Hospital LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Untch+M%22">Untch M</searchLink>; Department of Gynecology and Obstetrics, Helios Clinics Berlin-Buch, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Ditsch+N%22">Ditsch N</searchLink>; Gynecology, Obstetrics and Senology, Faculty of Medicine, University of Augsburg, Breast Center, University Hospital Augsburg, Augsburg, Germany; CCC WERA, Germany.<br /><searchLink fieldCode="AU" term="%22Hein+A%22">Hein A</searchLink>; Department of Gynecology and Obstetrics, Klinikum Esslingen, Esslingen, Germany.<br /><searchLink fieldCode="AU" term="%22Janni+W%22">Janni W</searchLink>; Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Taran+FA%22">Taran FA</searchLink>; Department of Gynecology and Gynecologic Oncology, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Medical Faculty and University Clinic of Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Lux+MP%22">Lux MP</searchLink>; Department of Gynecology and Obstetrics, Frauenklinik St. Louise, Paderborn, St. Josefs-Krankenhaus, Salzkotten, Germany; St. Vincenz Kliniken Salzkotten + Paderborn, Paderborn, Germany.<br /><searchLink fieldCode="AU" term="%22Wallwiener+D%22">Wallwiener D</searchLink>; Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Brucker+SY%22">Brucker SY</searchLink>; Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Fehm+TN%22">Fehm TN</searchLink>; Department of Gynecology and Obstetrics, Düsseldorf University Hospital, Düsseldorf, Germany; Center for Integrated Oncology Aachen Bonn Köln Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Schneeweiss+A%22">Schneeweiss A</searchLink>; National Center for Tumor Diseases, Heidelberg University Hospital, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Goossens+C%22">Goossens C</searchLink>; Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN (CCC-EMN), Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Engler+T%22">Engler T</searchLink>; Department of Obstetrics and Gynecology, University of Tübingen, Tübingen, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2025 Sep 09; Vol. 227, pp. 115689. <i>Date of Electronic Publication: </i>2025 Aug 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Observational Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40780076 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ejca.2025.115689 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 115689 Titles: – TitleFull: Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Michel LL – PersonEntity: Name: NameFull: Ziegler P – PersonEntity: Name: NameFull: Kreis P – PersonEntity: Name: NameFull: Hartkopf AD – PersonEntity: Name: NameFull: Wallwiener M – PersonEntity: Name: NameFull: Häberle L – PersonEntity: Name: NameFull: John N – PersonEntity: Name: NameFull: Kolberg HC – PersonEntity: Name: NameFull: Hadji P – PersonEntity: Name: NameFull: Tesch H – PersonEntity: Name: NameFull: Ettl J – PersonEntity: Name: NameFull: Lüftner D – PersonEntity: Name: NameFull: Müller V – PersonEntity: Name: NameFull: Belleville E – PersonEntity: Name: NameFull: Wimberger P – PersonEntity: Name: NameFull: Enzinger HM – PersonEntity: Name: NameFull: Huebner H – PersonEntity: Name: NameFull: Uhrig S – PersonEntity: Name: NameFull: Hack CC – PersonEntity: Name: NameFull: Krabisch P – PersonEntity: Name: NameFull: Fasching PA – PersonEntity: Name: NameFull: Wuerstlein R – PersonEntity: Name: NameFull: Untch M – PersonEntity: Name: NameFull: Ditsch N – PersonEntity: Name: NameFull: Hein A – PersonEntity: Name: NameFull: Janni W – PersonEntity: Name: NameFull: Taran FA – PersonEntity: Name: NameFull: Lux MP – PersonEntity: Name: NameFull: Wallwiener D – PersonEntity: Name: NameFull: Brucker SY – PersonEntity: Name: NameFull: Fehm TN – PersonEntity: Name: NameFull: Schneeweiss A – PersonEntity: Name: NameFull: Goossens C – PersonEntity: Name: NameFull: Engler T IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 09 Text: 2025 Sep 09 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1879-0852 Numbering: – Type: volume Value: 227 Titles: – TitleFull: European journal of cancer (Oxford, England : 1990) Type: main |
| ResultId | 1 |